CDC50A and neoplasm: As shown in Table 1, inoculations of 103, 104 or 105 CDC50A+Lin− cells were able to develop xenograft tumours in one-fourth, three-eighth or four-fifth of mice, respectively, whereas only administration of 105 CDC50A−Lin− cells was able to generate tumours in a quarter of mice.